GO:0033560 folate reductase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033560 (folate reductase activity) catalyzes the NADP+-dependent reduction of 7,8-dihydrofolate to folate, regenerating the tetrahydrofolate pool that fuels one-carbon metabolism.
• The reaction is the reverse of the canonical dihydrofolate reductase (DHFR) step and is central to maintaining folate in its oxidized, transport- and storage-competent form.
• DHFR and MTHFR are the principal enzymes that interconvert folate species and control flux into nucleotide synthesis and methylation.
• Folate-dependent one-carbon units are required for dTMP synthesis, methionine regeneration, and mitochondrial tRNA methylation, linking GO:0033560 to genome stability and translation.
• Altered folate reductase/DHFR activity is implicated in neural development, oligodendrocyte survival, autoimmune epigenetic reprogramming, and antiparasitic drug targeting.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of GO:0033560-related genes in human cell systems.
Description
Folate reductase activity (GO:0033560) is a molecular function defined by the reversible, NADP+-dependent interconversion of 7,8-dihydrofolate and folate. In the direction specified by the Gene Ontology, the enzyme reduces 7,8-dihydrofolate to folate while oxidizing NADPH to NADP+ and releasing a proton. This activity sits at the heart of one-carbon metabolism, the network that distributes methyl groups for nucleotide biosynthesis, amino acid homeostasis, and methylation reactions. Because folate cofactors cannot be synthesized de novo by humans, the balance between oxidized and reduced folate species must be continuously maintained by enzymes such as dihydrofolate reductase (DHFR) and methylenetetrahydrofolate reductase (MTHFR). For researchers, GO:0033560 is more than a textbook reaction. The folate pool it helps maintain supplies one-carbon units for dTMP and purine synthesis, for the methionine synthase reaction that regenerates S-adenosylmethionine, and for mitochondrial translation via folate-dependent tRNA methylation. Perturbations in this axis have been linked to neural tube defects, neurodevelopmental transitions, oligodendrocyte survival, autoimmune epigenetic landscapes, and malaria parasite viability. Consequently, assays that measure folate reductase activity, DHFR protein levels, and folate species distribution are widely used in cancer biology, neurobiology, immunology, and parasitology. This article integrates the QuickGO definition of GO:0033560 with verified PubMed literature to summarize its mechanism, the genes and proteins that carry or regulate it, its disease relevance, and the CRISPR-based experimental models and methods used to study it.
folate reductase activity At A Glance
| GO ID | GO:0033560 |
|---|---|
| GO term | folate reductase activity |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Definition | Catalysis of the reaction: 7,8-dihydrofolate + NADP+ = folate + NADPH + H+ |
| Major function | Interconversion of dihydrofolate and folate to sustain one-carbon metabolism |
| Cofactor | NADPH/NADP+ |
| Substrates | 7,8-dihydrofolate; NADP+ |
| Products | folate; NADPH; H+ |
| Representative enzymes | DHFR, MTHFR (folate interconversion network) |
| Related pathways | One-carbon metabolism, nucleotide biosynthesis, methylation |
What Is GO:0033560?
GO:0033560, folate reductase activity, is defined in QuickGO as the catalysis of the reaction: 7,8-dihydrofolate + NADP+ = folate + NADPH + H+. In other words, it is the enzymatic conversion of the oxidized folate derivative 7,8-dihydrofolate into folate, coupled to the oxidation of NADPH and release of a proton. This activity is the reverse direction of the classical dihydrofolate reductase (DHFR) reaction and is part of the broader folate interconversion network that maintains one-carbon donor pools.
Why Is folate reductase activity Important in Cell Biology?
Folate reductase activity matters because it helps set the redox and one-carbon balance of the cell. By converting 7,8-dihydrofolate to folate, the activity supports the regeneration of tetrahydrofolate species that donate methyl groups to dTMP, purines, methionine, and mitochondrial tRNA. When this balance is disturbed, cells experience altered nucleotide supply, epigenetic changes, and stress responses that have been observed in neurodevelopmental disorders, autoimmune conditions, and parasitic infections. For experimental biologists, GO:0033560 therefore provides a functional anchor for studying how folate flux influences proliferation, differentiation, and disease.
• Maintains the folate pool required for dTMP and purine synthesis, directly influencing DNA replication and repair.
• Supports methionine synthase activity and S-adenosylmethionine regeneration, linking folate to epigenetic methylation.
• Contributes to mitochondrial translation through folate-dependent tRNA methylation.
• Modulates neurogenic transitions in the developing neocortex via DHFR activity.
• Influences oligodendrocyte survival and differentiation through AMPKalpha signaling.
• Is a targetable vulnerability in Plasmodium falciparum, where DHFR inhibitors are antimalarial drugs.
• Connects MTHFR polymorphisms to disease risk, including vascular and neuropsychiatric phenotypes.
• Provides a mechanistic explanation for how folate status shapes autoimmune epigenetic landscapes.
• Serves as a pharmacodynamic readout for antifolate chemotherapy and antibiotic development.
• Enables causal testing of folate pathway genes using CRISPR knockout and knock-in models.
Molecular Mechanism of folate reductase activity
Substrate binding and cofactor selection
In simple terms: The enzyme first grabs its folate-like substrate and an NADPH molecule.
Folate reductase activity requires binding of 7,8-dihydrofolate and the reduced cofactor NADPH. The QuickGO definition specifies NADP+ as the electron acceptor in the reverse direction, meaning the enzyme operates near an NADP+/NADPH redox couple. Structural and kinetic studies of DHFR-family enzymes show that the pteridine ring of the folate substrate and the nicotinamide ring of the cofactor are positioned for hydride transfer, a conserved feature across species including Plasmodium falciparum DHFR.
Hydride transfer and proton release
In simple terms: A hydrogen unit is moved from NADPH to the substrate, and a proton is released.
The catalytic step of GO:0033560 is the reduction of 7,8-dihydrofolate to folate, coupled to NADPH oxidation and proton release. This reversible hydride transfer is the chemical core of the reaction described in QuickGO. In the broader folate cycle, the same redox chemistry underlies the interconversion of dihydrofolate and tetrahydrofolate species that feed one-carbon metabolism.
Coupling to one-carbon metabolism
In simple terms: The product folate feeds into the network that supplies methyl groups to the cell.
Folate generated by this activity enters the one-carbon pool, where it is converted into tetrahydrofolate derivatives that donate methyl groups to dTMP, purines, methionine, and mitochondrial tRNA. MTHFR acts as a key allosteric regulator of this network, balancing flux between nucleotide synthesis and methylation. Disruption of this coupling alters proliferation and differentiation programs in neural and glial cells.
Regulation by allostery and redox state
In simple terms: The enzyme's speed is tuned by the cell's energy and redox signals.
Because the reaction consumes NADPH and produces NADP+, folate reductase activity is sensitive to the cellular redox state and to the availability of reduced cofactors. MTHFR has been described as a key allosteric regulator that integrates one-carbon flux with cellular metabolic status. In oligodendrocytes, folate metabolism modulates AMPKalpha activity, providing a link between folate handling and energy-sensing pathways.
Pharmacological inhibition
In simple terms: Drugs can block this activity, which is useful against parasites and cancer.
Folate reductase and DHFR enzymes are established drug targets. Antimalarial 1,3,5-triazine derivatives have been designed and screened against Plasmodium falciparum DHFR, demonstrating that inhibition of folate interconversion is a viable antiparasitic strategy. In human cells, antifolates exploit the same dependency of proliferating cells on one-carbon supply.
Key Genes Involved in GO:0033560 folate reductase activity
The genes below encode enzymes, transporters, and regulatory proteins that carry out or modulate folate reductase activity (GO:0033560) and the surrounding one-carbon network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DHFR | Catalyzes dihydrofolate/folate interconversion, including the GO:0033560 reaction | Core enzyme for folate reductase activity assays and antifolate studies |
| MTHFR | Reduces 5,10-methylene-THF to 5-methyl-THF; allosteric regulator of one-carbon flux | C677T polymorphism linked to disease risk and epigenetic variation |
| MTR | Methionine synthase; uses 5-methyl-THF to regenerate methionine | Connects folate status to methylation and SAM supply |
| SHMT1 | Serine hydroxymethyltransferase; feeds one-carbon units into folate pool | Links serine metabolism to folate-dependent nucleotide synthesis |
| SHMT2 | Mitochondrial serine hydroxymethyltransferase | Supports mitochondrial one-carbon metabolism and translation |
| MTHFD1 | C1-tetrahydrofolate synthase; interconverts folate species | Determines flux between nucleotide and methylation pathways |
| MTHFD2 | Mitochondrial one-carbon enzyme | Supports mitochondrial folate metabolism and tRNA methylation |
| TYMS | Thymidylate synthase; consumes 5,10-methylene-THF for dTMP | Readout of folate-dependent nucleotide synthesis |
| GART | Purine synthesis enzyme using folate cofactors | Links folate pool to purine biosynthesis |
| ATIC | Bifunctional purine synthesis enzyme | Folate-dependent purine pathway component |
| SLC19A1 | Reduced folate carrier | Controls cellular folate uptake and availability |
| FOLR1 | Folate receptor alpha | Mediates folate transport and is relevant to drug targeting |
| AMPD2 | AMP deaminase; modulates AMPK-related energy signaling | Linked to folate-dependent oligodendrocyte survival |
| PRKAA1 | AMPKalpha catalytic subunit | Mediates folate-dependent metabolic signaling |
| P. falciparum DHFR | Parasite DHFR targeted by antifolates | Antimalarial drug discovery target |
How Is folate reductase activity Regulated?
Folate reductase activity is regulated at multiple levels. Allosterically, MTHFR acts as a key regulator of one-carbon metabolism, adjusting flux between nucleotide synthesis and methylation according to cellular demands. Redox regulation is intrinsic to the reaction because it consumes NADPH and produces NADP+, tying activity to the cellular redox balance. In specific cell types, folate metabolism intersects with energy-sensing pathways such as AMPKalpha, which modulates oligodendrocyte survival and differentiation. Genetic variation, notably the MTHFR C677T polymorphism, further tunes pathway capacity and has been associated with altered disease susceptibility.
folate reductase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DHFR | Neurogenic transitions in developing neocortex | Knockout and point-mutation human neural progenitor cells |
| MTHFR | Autoimmune epigenetic landscape; vascular and neuropsychiatric risk | Knock-in of C677T variant in immune cell lines |
| MTR | Methylation-related disorders | Knockout in hepatocyte or neuronal models |
| P. falciparum DHFR | Malaria | Parasite DHFR inhibition assays and resistance mutation models |
| SHMT2 | Mitochondrial translation defects | Knockout in mitochondrial reporter cell lines |
Neurodevelopmental and neurological disorders
DHFR activity controls neurogenic transitions in the developing neocortex, and its perturbation alters the timing of neuronal differentiation. Folate metabolism also regulates oligodendrocyte survival and differentiation through AMPKalpha signaling, linking GO:0033560-related flux to white matter biology. MTHFR polymorphisms have been associated with neuropsychiatric and vascular phenotypes in epidemiological studies.
Autoimmune and epigenetic disease
The MTHFR-folate axis modulates the epigenetic landscape in autoimmune diseases, where altered methylation capacity can influence immune gene expression. Because folate reductase activity helps supply methyl groups, changes in this pathway may contribute to the epigenetic reprogramming observed in autoimmunity.
Cancer and antiparasitic therapy
Proliferating cells depend on folate-dependent nucleotide synthesis, making folate reductase and DHFR attractive drug targets. In infectious disease, Plasmodium falciparum DHFR is the target of antimalarial 1,3,5-triazine derivatives, demonstrating the therapeutic relevance of inhibiting folate interconversion.
Mitochondrial translation defects
Mitochondrial translation requires folate-dependent tRNA methylation, so disruption of folate metabolism can impair mitochondrial gene expression. This connects GO:0033560-related pathways to mitochondrial disease mechanisms and to the metabolic stress responses observed in folate-deficient states.
From folate reductase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is DHFR required for neural differentiation timing? | DHFR knockout human neural progenitor cells |
| Does the MTHFR C677T variant alter methylation capacity? | Point-mutation knock-in of C677T in immune or endothelial cells |
| How does folate flux affect oligodendrocyte survival? | Knockout or overexpression of folate pathway genes in oligodendrocyte precursors |
| Can parasite DHFR be selectively inhibited? | Plasmodium falciparum DHFR enzyme assays and resistance mutants |
| Does mitochondrial folate metabolism control tRNA methylation? | SHMT2/MTHFD2 knockout cells with mitochondrial translation reporters |
| What is the effect of folate reductase overexpression on proliferation? | Doxycycline-inducible DHFR overexpression cell lines |
How to Study the folate reductase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NADPH oxidation assay | Folate reductase/DHFR catalytic rate | Enzyme kinetics and inhibitor screening |
| LC-MS folate profiling | Levels of folate species | Metabolic phenotyping of knockout cells |
| RNA-seq | Transcriptional changes | Pathway response to folate perturbation |
| Methylation array | DNA methylation status | Epigenetic effects of MTHFR variants |
| CRISPR knockout screen | Gene essentiality and modifiers | Identifying folate pathway dependencies |
| Mitochondrial translation reporter | Mitochondrial protein synthesis | Testing folate-dependent tRNA methylation |
| Parasite DHFR inhibition assay | Antimalarial drug potency | Screening triazine derivatives |
| Immunoblotting | Protein expression of DHFR/MTHFR | Validating knockout or overexpression models |
Enzymatic activity assays
Folate reductase activity can be measured spectrophotometrically by following NADPH oxidation or NADP+ reduction at 340 nm using 7,8-dihydrofolate as substrate, as described in classical DHFR assays. These assays are used to test inhibitors such as antimalarial triazine derivatives against Plasmodium falciparum DHFR.
Metabolite profiling
LC-MS-based profiling of folate species quantifies the balance between dihydrofolate, tetrahydrofolate, and methylated derivatives, providing a direct readout of GO:0033560-related flux. Such profiling is essential for linking genotype to one-carbon metabolic phenotype.
Transcriptomic and epigenomic analysis
RNA-seq and methylation arrays reveal how altered folate metabolism changes gene expression and DNA methylation, as studied in autoimmune epigenetic landscapes and MTHFR variant carriers. These methods connect molecular function to downstream cellular phenotypes.
CRISPR-based functional genomics
CRISPR knockout and knock-in screens can test the causal role of DHFR, MTHFR, and related genes in proliferation, differentiation, and drug response. Pooled library screening with bioinformatic analysis identifies modifiers of folate dependency across cell types.
How CRISPR Can Be Used to Study GO:0033560 folate reductase activity
Knockout
CRISPR knockout of DHFR or MTHFR in human cell lines removes the enzyme responsible for folate interconversion, allowing researchers to test whether GO:0033560 activity is required for proliferation, differentiation, or survival. Knockout models have been used to show that DHFR activity controls neurogenic transitions in the developing neocortex.
Point Mutation
Point-mutation models introduce disease-associated variants such as MTHFR C677T to test how subtle changes in enzyme activity alter one-carbon flux and epigenetic marks. These models are valuable for separating catalytic effects from protein stability effects.
Knock-in
Knock-in of tagged or reporter alleles enables tracking of DHFR or MTHFR expression and localization in live cells, linking GO:0033560 activity to specific subcellular compartments. Knock-in of resistance mutations in parasite DHFR supports antimalarial drug studies.
Overexpression
Overexpression of DHFR or MTHFR increases folate reductase capacity and can reveal dose-dependent effects on nucleotide synthesis, methylation, and drug sensitivity. Inducible overexpression systems allow temporal control of pathway activation.
How EDITGENE Supports folate reductase activity Research
Researchers studying folate reductase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as neural differentiation, oligodendrocyte survival, or drug resistance. EDITGENE provides the CRISPR tools and cell models required to move from correlation to causation in folate pathway research.
Contact EDITGENE today to design your custom CRISPR model for folate reductase activity research.
Frequently Asked Questions About folate reductase activity
What is folate reductase activity?
Folate reductase activity (GO:0033560) is the catalysis of the reaction 7,8-dihydrofolate + NADP+ = folate + NADPH + H+, as defined in QuickGO.
What genes are involved in folate reductase activity?
Key genes include DHFR, MTHFR, MTR, SHMT1, SHMT2, MTHFD1, MTHFD2, TYMS, and folate transporters such as SLC19A1 and FOLR1.
What is the difference between DHFR and folate reductase activity?
DHFR catalyzes the interconversion of dihydrofolate and tetrahydrofolate, and GO:0033560 describes the related reduction of 7,8-dihydrofolate to folate with NADPH oxidation.
How is folate reductase activity measured?
It is commonly measured by NADPH oxidation assays and by LC-MS profiling of folate species in cell extracts.
Why is folate reductase activity important in cancer?
Proliferating cancer cells depend on folate-dependent nucleotide synthesis, making this activity a target for antifolate drugs.
Does folate reductase activity affect brain development?
Yes, DHFR activity controls neurogenic transitions in the developing neocortex, and folate metabolism regulates oligodendrocyte survival.
What diseases are linked to MTHFR and folate metabolism?
MTHFR polymorphisms and folate imbalance have been linked to vascular, neuropsychiatric, and autoimmune phenotypes through epigenetic mechanisms.
Can CRISPR be used to study folate reductase activity?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are used to test causal roles of DHFR, MTHFR, and related genes.
Is folate reductase activity a drug target in malaria?
Yes, Plasmodium falciparum DHFR is targeted by antimalarial triazine derivatives, validating folate interconversion as a drug target.
What is the role of folate in mitochondrial translation?
Mitochondrial translation requires folate-dependent tRNA methylation, linking folate metabolism to mitochondrial gene expression.
Conclusion
Folate reductase activity (GO:0033560) is a compact but pivotal molecular function that maintains the folate pool needed for nucleotide synthesis, methylation, and mitochondrial translation. Its dysregulation has been linked to neurodevelopmental, autoimmune, and infectious disease contexts, and its enzymes are established drug targets. By combining QuickGO annotation with CRISPR-based causal models, researchers can dissect how this activity shapes cell fate and disease. EDITGENE supports this work with knockout, point-mutation, knock-in, overexpression, and screening services tailored to folate pathway biology.
References
- 1. Liew SC et al.. 2015. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases.. Eur J Med Genet 58(1):1-10 PMID: 25449138
- 2. Pietrzik K et al.. 2010. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics.. Clin Pharmacokinet 49(8):535-48 PMID: 20608755
- 3. Morscher RJ et al.. 2018. Mitochondrial translation requires folate-dependent tRNA methylation.. Nature 554(7690):128-132 PMID: 29364879
- 4. Saha S et al.. 2023. Dihydrofolate reductase activity controls neurogenic transitions in the developing neocortex.. Development 150(20) PMID: 37665322
- 5. Navarro-Rodríguez PM et al.. 2026. MTHFR‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review).. Int J Mol Med 57(3) PMID: 41574701
- 6. Weng Q et al.. 2017. Folate Metabolism Regulates Oligodendrocyte Survival and Differentiation by Modulating AMPKα Activity.. Sci Rep 7(1):1705 PMID: 28496133
- 7. Blomgren LKM et al.. 2026. 5,10-Methylenetetrahydrofolate Reductase─the Key Allosteric Regulator in One-Carbon Metabolism.. Biochemistry 65(6):627-636 PMID: 41758688
- 8. Choudhury AAK et al.. 2023. Hybrid PABA-glutamic acid conjugated 1,3,5-triazine derivatives: Design, synthesis, and antimalarial activity screening targeting Plasmodium falciparum dihydro folate reductase enzyme.. Chem Biol Drug Des 102(6):1336-1352 PMID: 37783571
